Aspirin 300mg in Acute Ischemic Stroke Management
Aspirin 300mg is indicated for acute ischemic stroke within 24-48 hours of symptom onset, provided there are no contraindications and the patient is not receiving thrombolytic therapy. 1
Evidence-Based Recommendations
Timing and Dosing
- Aspirin should be administered within 24-48 hours after stroke onset 1
- Dosage range of 160-300mg is supported by high-quality evidence 1
- The 300mg dose specifically was evaluated in the International Stroke Trial and showed benefit 1
Clinical Benefits
- Reduces risk of early recurrent ischemic stroke 1, 2
- Decreases mortality and dependency at follow-up 2
- For every 1000 patients treated with aspirin:
Important Precautions
- Aspirin should NOT be used as a substitute for thrombolytic therapy in eligible patients 1
- Administration should be delayed until 24 hours after IV alteplase (thrombolysis) 1
- Brain imaging must be performed before administration to exclude intracranial hemorrhage 1
Administration Considerations
Route of Administration
- Oral administration is preferred if the patient can swallow safely
- For patients with dysphagia:
Bleeding Risk
- Small but significant increase in risk of:
- This risk is outweighed by the benefits in reduction of recurrent stroke and improved outcomes 2, 3
Algorithm for Decision-Making
- Confirm ischemic stroke diagnosis with brain imaging
- Determine if patient is eligible for thrombolysis:
- If YES: Administer thrombolysis first, then start aspirin after 24 hours
- If NO: Proceed to step 3
- Check for contraindications to aspirin:
- Active bleeding
- Known aspirin allergy
- Recent gastrointestinal bleeding
- If no contraindications, administer aspirin 300mg:
- Within 24-48 hours of symptom onset
- Choose appropriate route based on swallowing ability
Special Considerations
- The benefit of aspirin appears primarily related to prevention of early recurrent events rather than limiting neurological consequences of the initial stroke 1
- While some guidelines have moved away from specifying the exact dose, the evidence specifically supports doses between 160-300mg 1
- The 2018 AHA/ASA guidelines removed the specific 325mg dosing recommendation that was in previous guidelines, acknowledging that clinical trials supporting aspirin use included doses of 160-300mg 1
Aspirin 300mg represents a well-established, evidence-based intervention that provides a modest but significant benefit in reducing mortality and disability following acute ischemic stroke.